Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lederman

Showing results (151-160 of 707) with videos related to

Pageof 71
Sort By:
Refu'At Ha-Peh Veha-Shinayim (1993)|March 25, 2015
[Biocompatibility of composites--literature review]M Lederman, E Sharon, M Lipovezky-Adler, et al.
The Journal of Clinical Investigation|September 7, 2001
HIV-1 infection impairs cell cycle progression of CD4(+) T cells without affecting early activation responsesS F Sieg, C V Harding, M M Lederman
AIDS (London, England)|February 24, 2001
Should physicians withhold highly active antiretroviral therapies from HIV-AIDS patients who are thought to be poorly adherent to treatment?S Sollitto, M Mehlman, S Youngner, et al.
Health Affairs Scholar|April 11, 2025
Substantial variation among Medicare beneficiaries in the impact from 2025 Part D out of pocket spending capsDebra M Lederman, Alexander L Olssen, Mark V Pauly
JAMA|August 15, 2006
Biology of CCR5 and its role in HIV infection and treatmentMichael M Lederman, Adam Penn-Nicholson, Michael Cho, et al.
The Journal of Laboratory and Clinical Medicine|April 2, 1998
Rationale for immune-based therapies for HIV-1 infectionH Valdez, L Al-Harthi, A Landay, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2006
Cutting edge: human beta defensin 3--a novel antagonist of the HIV-1 coreceptor CXCR4Zhimin Feng, George R Dubyak, Michael M Lederman, et al.
AIDS (London, England)|October 18, 2008
Pulmonary arterial hypertension and its association with HIV infection: an overviewMichael M Lederman, Daniel Sereni, Gérald Simonneau, et al.
AIDS (London, England)|October 18, 2008
Editors' perspective and conclusionsMichael M Lederman, Daniel Sereni, Gérald Simonneau, et al.
Virology|January 1, 1993
The complete nucleotide sequence of parvovirus LuIII and localization of a unique sequence possibly responsible for its encapsidation patternN Diffoot, K C Chen, R C Bates, et al.
Pageof 71

Showing results (151-160 of 707) with videos related to

Sort By:
Pageof 71
Refu'At Ha-Peh Veha-Shinayim (1993)|March 25, 2015
[Biocompatibility of composites--literature review]M Lederman, E Sharon, M Lipovezky-Adler, et al.
The Journal of Clinical Investigation|September 7, 2001
HIV-1 infection impairs cell cycle progression of CD4(+) T cells without affecting early activation responsesS F Sieg, C V Harding, M M Lederman
AIDS (London, England)|February 24, 2001
Should physicians withhold highly active antiretroviral therapies from HIV-AIDS patients who are thought to be poorly adherent to treatment?S Sollitto, M Mehlman, S Youngner, et al.
Health Affairs Scholar|April 11, 2025
Substantial variation among Medicare beneficiaries in the impact from 2025 Part D out of pocket spending capsDebra M Lederman, Alexander L Olssen, Mark V Pauly
JAMA|August 15, 2006
Biology of CCR5 and its role in HIV infection and treatmentMichael M Lederman, Adam Penn-Nicholson, Michael Cho, et al.
The Journal of Laboratory and Clinical Medicine|April 2, 1998
Rationale for immune-based therapies for HIV-1 infectionH Valdez, L Al-Harthi, A Landay, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2006
Cutting edge: human beta defensin 3--a novel antagonist of the HIV-1 coreceptor CXCR4Zhimin Feng, George R Dubyak, Michael M Lederman, et al.
AIDS (London, England)|October 18, 2008
Pulmonary arterial hypertension and its association with HIV infection: an overviewMichael M Lederman, Daniel Sereni, Gérald Simonneau, et al.
AIDS (London, England)|October 18, 2008
Editors' perspective and conclusionsMichael M Lederman, Daniel Sereni, Gérald Simonneau, et al.
Virology|January 1, 1993
The complete nucleotide sequence of parvovirus LuIII and localization of a unique sequence possibly responsible for its encapsidation patternN Diffoot, K C Chen, R C Bates, et al.
Pageof 71